Post by UCL

UCL is proud to share that Professor Waseem Qasim and patient Alyssa Tapley have been jointly named on the TIME100 Health list 2026. Their recognition follows a world‑first clinical trial led by Professor Qasim (UCL Great Ormond Street Institute of Child Health) and colleagues at Great Ormond Street Hospital, using an innovative gene‑editing technique known as base‑editing to engineer immune cells capable of treating a previously untreatable form of blood cancer: T‑cell acute lymphoblastic leukaemia (T‑ALL). Alyssa, the first patient to receive this treatment, has spoken powerfully about its life‑changing impact. 💜 💬 Professor Qasim said: “I feel incredibly privileged… but this is really down to the work of the amazingly dedicated teams that pull together to find new ways to help patients.” 🔗 Read more: https://lnkd.in/eGYSeHBP This achievement builds on UCL’s continued presence in the TIME100 Health lists in 2024 and 2025. UCL Faculty of Population Health Sciences, Great Ormond Street Hospital for Children NHS Foundation Trust, TIME